StrokeWear for Chronic Stroke Recovery
Trial Summary
What is the purpose of this trial?
The proposed study is a two-arm randomized clinical trial designed to assess the effects of the StrokeWear system on clinical outcomes over a period of 6-months in chronic stroke survivors. The Intervention group will use StrokeWear system in combination to a motor and behavioral home intervention whereas the Control group will follow usual care which consists of a home-exercise plan (HEP).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
What data supports the effectiveness of the StrokeWear treatment for chronic stroke recovery?
Research shows that wearable sensors can help monitor and encourage movement in stroke patients, leading to increased use of the affected arm. Studies found that reminders from these devices can significantly boost arm activity, suggesting that StrokeWear could be a promising tool for improving motor recovery in stroke patients.12345
How is the StrokeWear treatment different from other stroke recovery treatments?
StrokeWear is unique because it uses wearable technology to provide real-time feedback on motor performance, helping patients improve their movement and daily activities. This approach allows for personalized rehabilitation outside of clinical settings, which can be more convenient and adaptable to individual needs compared to traditional in-person therapies.12678
Research Team
Paolo Bonato, PhD
Principal Investigator
Spaulding Rehabilitation Hospital
Eligibility Criteria
This trial is for chronic stroke survivors aged 18-85 with mild to moderate arm weakness from a stroke that happened between 6 months and 5 years ago. They must be able to understand the study, use a tablet or smartphone, and not have severe spasticity, visual impairments preventing app use, other neurological diseases, severe proprioceptive deficits, recent fractures or wounds in the affected arm, current enrollment in another upper extremity rehab program.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Baseline evaluation of upper-extremity motor function and other assessments
Treatment
Intervention group uses StrokeWear system with motor and behavioral home intervention; Control group follows usual care with home-exercise plan
Follow-up Evaluation
Evaluation visits at 3 months and 6 months to assess clinical outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- StrokeWear Motor and Behavioral Intervention
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spaulding Rehabilitation Hospital
Lead Sponsor
MGH Institute of Health Professions
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
BioSensics
Industry Sponsor